Dynavax Technologies Corp... (DVAX)
NASDAQ: DVAX
· Real-Time Price · USD
10.18
-0.09 (-0.88%)
At close: Jun 16, 2025, 3:59 PM
10.03
-1.47%
After-hours: Jun 16, 2025, 06:54 PM EDT
-0.88% (1D)
| Bid | 9.8 |
| Market Cap | 1.22B |
| Revenue (ttm) | 294.62M |
| Net Income (ttm) | -60.07M |
| EPS (ttm) | -0.5 |
| PE Ratio (ttm) | -20.36 |
| Forward PE | 19.35 |
| Analyst | Buy |
| Ask | 10.43 |
| Volume | 1,138,160 |
| Avg. Volume (20D) | 2,275,771 |
| Open | 10.29 |
| Previous Close | 10.27 |
| Day's Range | 10.17 - 10.45 |
| 52-Week Range | 9.22 - 14.63 |
| Beta | 1.04 |
About DVAX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DVAX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DVAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-10.99%
Dynavax Technologies shares are trading lower afte...
Unlock content with
Pro Subscription
2 months ago
-6.66%
Shares of vaccine stocks are trading lower after CDC advisers begins a review of vaccine guidelines and discussed a more narrow use of COVID-19 booster shots.
3 weeks ago · seekingalpha.com
Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking GoodDynavax Technologies' stock has dropped 25% since my last 'Hold' rating in February 2025. The company's HEPLISAV-B continues to grow at significant rates. DVAX has ample liquidity supporting a balance...
1 month ago · seekingalpha.com
Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call TranscriptDynavax Technologies Corporation (NASDAQ:DVAX ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Paul Cox - Vice President, Investor Relations & Corporate Communications Ry...
